Shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) gapped down prior to trading on Monday . The stock had previously closed at $16.26, but opened at $14.84. Allscripts Healthcare Solutions shares last traded at $13.83, with a volume of 9192700 shares changing hands.
A number of analysts recently issued reports on the company. Evercore ISI assumed coverage on Allscripts Healthcare Solutions in a research report on Thursday, January 18th. They issued an “outperform” rating and a $17.50 target price for the company. TheStreet raised Allscripts Healthcare Solutions from a “c” rating to a “b-” rating in a research report on Thursday. Cantor Fitzgerald reissued a “buy” rating and issued a $17.00 target price on shares of Allscripts Healthcare Solutions in a research report on Sunday, January 28th. BidaskClub raised Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research report on Friday. Finally, Robert W. Baird upped their target price on Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the company an “outperform” rating in a research report on Friday, November 3rd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $15.85.
The company has a quick ratio of 0.98, a current ratio of 0.97 and a debt-to-equity ratio of 1.33. The firm has a market capitalization of $2,498.82, a PE ratio of -12.69, a price-to-earnings-growth ratio of 1.95 and a beta of 1.18.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings data on Thursday, February 15th. The software maker reported $0.18 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.18. Allscripts Healthcare Solutions had a positive return on equity of 7.36% and a negative net margin of 10.88%. The company had revenue of $547.00 million during the quarter, compared to analysts’ expectations of $524.05 million. During the same period last year, the firm earned $0.14 EPS. The firm’s revenue for the quarter was up 27.5% on a year-over-year basis. equities analysts predict that Allscripts Healthcare Solutions Inc will post 0.59 EPS for the current fiscal year.
In other news, President Richard J. Poulton sold 15,000 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $14.26, for a total transaction of $213,900.00. Following the completion of the transaction, the president now directly owns 1,351,773 shares of the company’s stock, valued at approximately $19,276,282.98. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP James Hewitt sold 36,796 shares of the stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $14.11, for a total value of $519,191.56. Following the transaction, the senior vice president now directly owns 181,766 shares of the company’s stock, valued at $2,564,718.26. The disclosure for this sale can be found here. Insiders have sold a total of 56,796 shares of company stock valued at $804,842 over the last ninety days. 0.91% of the stock is owned by insiders.
Several hedge funds have recently modified their holdings of MDRX. Fisher Asset Management LLC purchased a new position in shares of Allscripts Healthcare Solutions during the 3rd quarter worth approximately $33,351,000. Redmile Group LLC purchased a new position in shares of Allscripts Healthcare Solutions during the 4th quarter worth approximately $25,762,000. Systematic Financial Management LP raised its stake in shares of Allscripts Healthcare Solutions by 1,215.3% during the 3rd quarter. Systematic Financial Management LP now owns 1,853,300 shares of the software maker’s stock worth $26,372,000 after buying an additional 1,712,395 shares in the last quarter. State Street Corp raised its stake in shares of Allscripts Healthcare Solutions by 28.6% during the 2nd quarter. State Street Corp now owns 5,975,551 shares of the software maker’s stock worth $76,251,000 after buying an additional 1,330,721 shares in the last quarter. Finally, Janney Capital Management LLC raised its stake in shares of Allscripts Healthcare Solutions by 239.8% during the 3rd quarter. Janney Capital Management LLC now owns 997,009 shares of the software maker’s stock worth $14,187,000 after buying an additional 703,598 shares in the last quarter.
ILLEGAL ACTIVITY NOTICE: “Allscripts Healthcare Solutions (MDRX) Shares Gap Down to $14.84” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/19/allscripts-healthcare-solutions-mdrx-shares-gap-down-to-14-84.html.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.